PROGYNY INC (PGNY) Stock Fundamental Analysis
NASDAQ:PGNY • US74340E1038
17.72 USD
+0.12 (+0.68%)
Last: Mar 3, 2026, 11:30 AM
We assign a fundamental rating of 7 out of 10 to PGNY. PGNY was compared to 101 industry peers in the Health Care Providers & Services industry. PGNY gets an excellent profitability rating and is at the same time showing great financial health properties. PGNY is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, PGNY could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
- PGNY had positive earnings in the past year.
- PGNY had a positive operating cash flow in the past year.
- PGNY had positive earnings in each of the past 5 years.
- PGNY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- PGNY has a Return On Assets of 7.88%. This is amongst the best in the industry. PGNY outperforms 91.09% of its industry peers.
- With a decent Return On Equity value of 11.34%, PGNY is doing good in the industry, outperforming 74.26% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 10.67%, PGNY belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for PGNY is in line with the industry average of 9.12%.
- The last Return On Invested Capital (10.67%) for PGNY is above the 3 year average (9.10%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.88% | ||
| ROE | 11.34% | ||
| ROIC | 10.67% |
ROA(3y)8.34%
ROA(5y)9.8%
ROE(3y)11.81%
ROE(5y)13.92%
ROIC(3y)9.1%
ROIC(5y)7.81%
1.3 Margins
- PGNY has a better Profit Margin (4.54%) than 76.24% of its industry peers.
- In the last couple of years the Profit Margin of PGNY has declined.
- Looking at the Operating Margin, with a value of 7.06%, PGNY is in the better half of the industry, outperforming 72.28% of the companies in the same industry.
- In the last couple of years the Operating Margin of PGNY has grown nicely.
- PGNY has a Gross Margin (23.63%) which is comparable to the rest of the industry.
- PGNY's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.06% | ||
| PM (TTM) | 4.54% | ||
| GM | 23.63% |
OM growth 3Y33.54%
OM growth 5Y21.46%
PM growth 3Y5.54%
PM growth 5Y-19.56%
GM growth 3Y3.58%
GM growth 5Y3.06%
2. Health
2.1 Basic Checks
- PGNY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, PGNY has less shares outstanding
- PGNY has less shares outstanding than it did 5 years ago.
- PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- PGNY has an Altman-Z score of 6.91. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
- PGNY has a better Altman-Z score (6.91) than 93.07% of its industry peers.
- PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.91 |
ROIC/WACC1.24
WACC8.61%
2.3 Liquidity
- PGNY has a Current Ratio of 2.73. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
- PGNY's Current ratio of 2.73 is amongst the best of the industry. PGNY outperforms 84.16% of its industry peers.
- PGNY has a Quick Ratio of 2.73. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
- PGNY has a better Quick ratio (2.73) than 84.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 2.73 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 14.04% over the past year.
- Measured over the past years, PGNY shows a very strong growth in Earnings Per Share. The EPS has been growing by 52.04% on average per year.
- Looking at the last year, PGNY shows a quite strong growth in Revenue. The Revenue has grown by 10.40% in the last year.
- PGNY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.16% yearly.
EPS 1Y (TTM)14.04%
EPS 3Y29.4%
EPS 5Y52.04%
EPS Q2Q%16.67%
Revenue 1Y (TTM)10.4%
Revenue growth 3Y17.87%
Revenue growth 5Y30.16%
Sales Q2Q%6.69%
3.2 Future
- PGNY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.30% yearly.
- Based on estimates for the next years, PGNY will show a small growth in Revenue. The Revenue will grow by 5.69% on average per year.
EPS Next Y62.1%
EPS Next 2Y38.14%
EPS Next 3Y36.62%
EPS Next 5Y27.3%
Revenue Next Year8.37%
Revenue Next 2Y9.21%
Revenue Next 3Y7.86%
Revenue Next 5Y5.69%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 27.26, the valuation of PGNY can be described as expensive.
- PGNY's Price/Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.13, PGNY is valued at the same level.
- The Price/Forward Earnings ratio is 16.82, which indicates a correct valuation of PGNY.
- PGNY's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PGNY is cheaper than 73.27% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of PGNY to the average of the S&P500 Index (28.11), we can say PGNY is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.26 | ||
| Fwd PE | 16.82 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, PGNY is valued a bit cheaper than the industry average as 73.27% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of PGNY indicates a rather cheap valuation: PGNY is cheaper than 89.11% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.57 | ||
| EV/EBITDA | 9.73 |
4.3 Compensation for Growth
- PGNY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of PGNY may justify a higher PE ratio.
- A more expensive valuation may be justified as PGNY's earnings are expected to grow with 36.62% in the coming years.
PEG (NY)0.44
PEG (5Y)0.52
EPS Next 2Y38.14%
EPS Next 3Y36.62%
5. Dividend
5.1 Amount
- No dividends for PGNY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:PGNY (3/3/2026, 11:30:30 AM)
17.72
+0.12 (+0.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26 2026-02-26/amc
Earnings (Next)05-06 2026-05-06
Inst Owners104.67%
Inst Owner Change0.62%
Ins Owners1.48%
Ins Owner Change0.54%
Market Cap1.45B
Revenue(TTM)1.29B
Net Income(TTM)58.52M
Analysts83.53
Price Target30.79 (73.76%)
Short Float %4.98%
Short Ratio2.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.44%
Min EPS beat(2)-5.34%
Max EPS beat(2)14.22%
EPS beat(4)2
Avg EPS beat(4)2.94%
Min EPS beat(4)-11.77%
Max EPS beat(4)14.63%
EPS beat(8)4
Avg EPS beat(8)4.01%
EPS beat(12)8
Avg EPS beat(12)21.97%
EPS beat(16)12
Avg EPS beat(16)74.68%
Revenue beat(2)2
Avg Revenue beat(2)2.09%
Min Revenue beat(2)1.53%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)2.33%
Min Revenue beat(4)1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)5
Avg Revenue beat(8)0.19%
Revenue beat(12)8
Avg Revenue beat(12)0.58%
Revenue beat(16)10
Avg Revenue beat(16)0.45%
PT rev (1m)-0.06%
PT rev (3m)4.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.44%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.83%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.26 | ||
| Fwd PE | 16.82 | ||
| P/S | 1.13 | ||
| P/FCF | 7.57 | ||
| P/OCF | 6.9 | ||
| P/B | 2.81 | ||
| P/tB | 2.96 | ||
| EV/EBITDA | 9.73 |
EPS(TTM)0.65
EY3.67%
EPS(NY)1.05
Fwd EY5.95%
FCF(TTM)2.34
FCFY13.21%
OCF(TTM)2.57
OCFY14.48%
SpS15.73
BVpS6.3
TBVpS5.98
PEG (NY)0.44
PEG (5Y)0.52
Graham Number9.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.88% | ||
| ROE | 11.34% | ||
| ROCE | 16.85% | ||
| ROIC | 10.67% | ||
| ROICexc | 25.05% | ||
| ROICexgc | 28.27% | ||
| OM | 7.06% | ||
| PM (TTM) | 4.54% | ||
| GM | 23.63% | ||
| FCFM | 14.88% |
ROA(3y)8.34%
ROA(5y)9.8%
ROE(3y)11.81%
ROE(5y)13.92%
ROIC(3y)9.1%
ROIC(5y)7.81%
ROICexc(3y)21.68%
ROICexc(5y)17.45%
ROICexgc(3y)23.75%
ROICexgc(5y)19.08%
ROCE(3y)14.37%
ROCE(5y)12.33%
ROICexgc growth 3Y51.65%
ROICexgc growth 5Y21.09%
ROICexc growth 3Y48.79%
ROICexc growth 5Y23.47%
OM growth 3Y33.54%
OM growth 5Y21.46%
PM growth 3Y5.54%
PM growth 5Y-19.56%
GM growth 3Y3.58%
GM growth 5Y3.06%
F-Score6
Asset Turnover1.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 372.07% | ||
| Cap/Sales | 1.43% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 219.12% | ||
| Profit Quality | 327.72% | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 2.73 | ||
| Altman-Z | 6.91 |
F-Score6
WACC8.61%
ROIC/WACC1.24
Cap/Depr(3y)234.02%
Cap/Depr(5y)213.68%
Cap/Sales(3y)0.74%
Cap/Sales(5y)0.61%
Profit Quality(3y)315.29%
Profit Quality(5y)247.21%
High Growth Momentum
Growth
EPS 1Y (TTM)14.04%
EPS 3Y29.4%
EPS 5Y52.04%
EPS Q2Q%16.67%
EPS Next Y62.1%
EPS Next 2Y38.14%
EPS Next 3Y36.62%
EPS Next 5Y27.3%
Revenue 1Y (TTM)10.4%
Revenue growth 3Y17.87%
Revenue growth 5Y30.16%
Sales Q2Q%6.69%
Revenue Next Year8.37%
Revenue Next 2Y9.21%
Revenue Next 3Y7.86%
Revenue Next 5Y5.69%
EBIT growth 1Y34.87%
EBIT growth 3Y57.41%
EBIT growth 5Y58.1%
EBIT Next Year12.56%
EBIT Next 3Y11.25%
EBIT Next 5Y6.96%
FCF growth 1Y10.41%
FCF growth 3Y35.46%
FCF growth 5Y40.4%
OCF growth 1Y17.36%
OCF growth 3Y37.76%
OCF growth 5Y42.16%
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
Can you provide the valuation status for PROGYNY INC?
ChartMill assigns a valuation rating of 6 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What is the earnings growth outlook for PROGYNY INC?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 62.1% in the next year.